Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


April 26, 2015 9:08 PM ET

Pharmaceuticals

Company Overview of InKine Pharmaceutical Company, Inc.

Key Executives for InKine Pharmaceutical Company, Inc.

NameBoard RelationshipsTitleAge
John Cullen Ph.D., J.D.No RelationshipsSenior Vice President, Secretary and General Counsel76
Jeffrey S. Arcara No RelationshipsVice President of Commercial Development--
Robyn G. Karlstadt M.D.No RelationshipsVice President of Clinical Operations--
Stephen Skiendzielewski No RelationshipsVice President of Manufacturing--
Del Humphreys No RelationshipsSenior Vice President of Sales--

InKine Pharmaceutical Company, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Thomas P. Stagnaro 25 RelationshipsImmuMed, Inc.71
Robert F. Apple 3 RelationshipsAntares Pharma Inc.47
Norman D. Schellenger 3 RelationshipsDuke University82
John R. Leone 7 RelationshipsPaul Capital Healthcare66
View All Board Members

InKine Pharmaceutical Company, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Nominating Committee Thomas P. Stagnaro25 Relationships2 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
433.3K
Bonus
538.8K
Total Short Term Compensation
622.6K
Total Value of Options
30.2M
Compensation as of Fiscal Year
InKine Pharmaceutical Company, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

The Clorox Company Announces Retirement of Daniel Boggan as Directors, Effective May 13, 2015
April 24, 2015 9:00 PM ET
Worldwise Promotes Jeff Leh to Vice President of Sales
April 22, 2015 10:15 AM ET
Oil-Dri Corp. of America Announces Management Changes
April 17, 2015 8:15 PM ET
P&G Announces Executive Changes
April 14, 2015 1:58 PM ET
David Charne Joins Aunt Fannie's Board of Directors
April 14, 2015 1:38 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact InKine Pharmaceutical Company, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.